TCA
DXCM icon

Transcend Capital Advisors’s DexCom DXCM Stock Holding History

Transcend Capital Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$228K Buy
+3,381
New +$225K 0.02% 732
2024
Q3 		– Sell
-3,511
Closed -$398K – 625
2024
Q2 		$398K Sell
3,511
-12
-0.3% -$1.52K 0.03% 403
2024
Q1 		$489K Buy
+3,523
New +$443K 0.04% 327

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Transcend Capital Advisors's DXCM Position: Q2 2026 in Review

Transcend Capital Advisors opened a new position in DexCom (DXCM) in Q2 2026: 3,381 shares worth $228K. The stake represents 0.02% of the portfolio and ranks #732 among its holdings. This is a return to the name: Transcend Capital Advisors previously reported a position in DXCM as recently as Q2 2024.

Transcend Capital Advisors first reported a position in DXCM in Q1 2024 and has held it in 3 quarters since. The position peaked at $489K in Q1 2024. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Transcend Capital Advisors held 3,381 shares of DexCom worth $228K as of Q2 2026.
  • DexCom was a new Transcend Capital Advisors position in Q2 2026.
  • DexCom made up 0.02% of Transcend Capital Advisors's portfolio in Q2 2026, its #732 holding.
  • Transcend Capital Advisors first reported a position in DexCom in Q1 2024 and has held it in 3 quarters since.
  • Transcend Capital Advisors's DexCom position peaked at $489K in Q1 2024.
  • 976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Transcend Capital Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.